Non-sterile nitrile examination gloves 240 and 300 mm
Original notice title
France – Medical consumables – SAD GANTS25 - Fourniture de GANTS D'EXAMEN NON STERILES, EN NITRILE 240 et 300 mm
Opportunity Score
Why this score?
Opportunity
50 / 100
Complexity
20 / 100
Risk factors
Lack of estimated value, detailed eligibility criteria, and award criteria increases uncertainty and may hide unfavorab...
While DPS provides flexibility, actual contracts may be subject to mini-competitions with varying terms and conditions.
Restricted procedure — pre-qualification required
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Dynamic Purchasing System (DPS)
- Supplies contract
- 1 lot
- Duration until Apr 2035
- Supply of non-sterile nitrile examination gloves of lengths 240 mm and 300 mm
- Deliveries to various healthcare establishments in the Bouches-du-Rhône department, France
Show full summary
This is a restricted procedure for a Dynamic Purchasing System (DPS) for the supply of non-sterile nitrile examination gloves (240 mm and 300 mm) to the Assistance Publique Hôpitaux de Marseille (AP-HM) and potentially other healthcare establishments in the Bouches-du-Rhône department, France. The DPS runs from April 4, 2025 to April 2, 2035, during which eligible suppliers can submit tenders for specific contracts. No estimated value, award criteria, or detailed eligibility criteria are provided in the available data.
Risks
Lack of estimated value, detailed eligibility criteria, and award criteria increases uncertainty and may hide unfavorab...
While DPS provides flexibility, actual contracts may be subject to mini-competitions with varying terms and conditions.
Restricted procedure — pre-qualification required
No procurement documents available
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Restricted procedure: interested suppliers must first apply for admission to the DPS
- Selection criteria as per article 3.3 of the 'Règlement de Consultation' (not provided in the available data)
Administrative
- Electronic submission required via the French public procurement platform
Requirements may be incomplete.
Award Criteria
Lot 1
Buyer
Location
Marseille, FRA
Website
Buyer profile
Identifier
26130008100484
Activity
Health
Lots (1)
LOT-0001
Non-sterile nitrile examination gloves 240 and 300 mm
Supply of non-sterile nitrile examination gloves in two lengths (240 mm and 300 mm). Deliveries may occur across all establishments of the GHT Hôpitaux de Provence in Bouches-du-Rhône. The DPS spans 10 years.
Location
Duration
Category
Award Criteria
Deadline
Award details
GANTS D'EXAMEN NON STERILES, EN NITRILE 240 et 300 mm
Additional CPV codes
Value note
Show original TED data
Original lot title
GANTS D'EXAMEN NON STERILES, EN NITRILE 240 et 300 mm
Original TED description
GANTS D'EXAMEN NON STERILES, EN NITRILE 240 et 300 mm
Procurement Details
- Publication date
- 03 Apr 2025
- Languages
- French
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 218275-2025
Documents (1)
Similar tenders
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den genannten Wirkstoffen mit Abschlussmöglichkeit im Rahmen des sogenannten Open-House-Verfahrens.
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Omalizumab (ATC-Code nach WHO: R03DX05)
Opportunity Score
Why this score?
Opportunity
50 / 100
Complexity
20 / 100
Risk factors
Lack of estimated value, detailed eligibility criteria, and award criteria increases uncertainty and may hide unfavorab...
While DPS provides flexibility, actual contracts may be subject to mini-competitions with varying terms and conditions.
Restricted procedure — pre-qualification required
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications